Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|September 1, 2016

Value-Based Decisions in Diabetes: Evaluating Safety, Efficacy, and Costs of Therapeutic Alternatives

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Diabetes | Image Credit: © Renata Hamuda-stock.adobe.com

Social Factors Shape Diabetes, Dementia Risk Across Populations

ByMaggie L. Shaw

June 6th 2026

Alyson K. Myers, MD

Why CGM Access and Diabetes Amputations Are Part of the Same Systemic Problem: Alyson K. Myers, MD

ByGiuliana Grossi,Alyson K. Myers, MD

June 6th 2026

Alyson K. Myers, MD

Culturally Tailored Diabetes Care Can Improve Outcomes and Reduce Costs: Alyson K. Myers, MD

ByGiuliana Grossi,Alyson K. Myers, MD

June 6th 2026

Glucose monitoring | Image Credit: © Елена Бутусова-stock.adobe.com

AI Reshaping Diabetes Care From Nutrition to Clinical Decisions

ByMaggie L. Shaw

June 6th 2026

Kevin Kaiserman, MD

INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD

ByGiuliana Grossi,Kevin Kaiserman, MD

June 6th 2026

Trending on AJMC

Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention

INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD

AI Reshaping Diabetes Care From Nutrition to Clinical Decisions

Contributor: How to Pair Data With Clinical Care to Manage Health Care Costs

First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD